May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Lipid-mediated Gene Transfer of EGFP into Human Corneal Endothelial Cells (HCEC)
Author Affiliations & Notes
  • H. Dannowski
    Ophthalmology, HU Berlin Charité CVK, Berlin, Germany
  • J. Bednarz
    Ophthalmology, Universitätsaugenklinik Hamburg Eppendorf, Hamburg, Germany
  • R. Reszka
    Max Delbrück Centre for Molecular Medicine, Berlin, Germany
  • K. Engelmann
    Max Delbrück Centre for Molecular Medicine, Berlin, Germany
  • U. Pleyer
    Max Delbrück Centre for Molecular Medicine, Berlin, Germany
  • Footnotes
    Commercial Relationships  H. Dannowski, None; J. Bednarz, None; R. Reszka, None; K. Engelmann, None; U. Pleyer, None.
  • Footnotes
    Support  DFG Pl150/9-1, Re93/7-1
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 845. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Dannowski, J. Bednarz, R. Reszka, K. Engelmann, U. Pleyer; Lipid-mediated Gene Transfer of EGFP into Human Corneal Endothelial Cells (HCEC) . Invest. Ophthalmol. Vis. Sci. 2003;44(13):845.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Although in generally not as efficient as viral vectors, nonviral systems have potential advantages in gene transfer. These include a lack of immunogenicity and commercially availability. The purpose of this study was to examine efficiency and toxicity of different nonviral transfection reagents by FACS-analysis after transfection of human corneal endothelial cells (HCEC). Methods: An immortalized cell line of HCEC was cultured and transfected with a plasmid coding for EGFP. Various transfection reagents including DAC30, Fugene 6 (Roche), Lipofectamine, Lipofectin, CellFectin, DMRIE-C (Gibco), Effectene, SuperFect (Qiagen) were studied for gene transfer. HCEC were seeded at 4x104 cells/well in 24 well plates, transfected and quantified 24 hours after transfection. Untransfected HCEC served as controls. Efficiency was determined by EGFP-Fluorescence measurement and toxicity by propidium iodide (PI) staining. Results: Gene transfer efficiency and toxicity of the transfection reagents are strongly dependent on the lipid:DNA ratios and concentrations as indicated by EGFP expression and PI staining. For every transfecting agent conditions need to be optimised. In these experiments efficiencies of about 10% with toxicities of about 3% were decided to be useful in transfecting HCEC. The agents are listed here in order of their applicability: Lipofectin > DMRIE-C > FuGene6, Effectene > DAC30 > CellFectin > Lipofectamine > Superfect. Conclusions: Transfection with EGFP and subsequently PI staining is a feasible way for selection of optimal lipid:DNA ratios for the highest potential efficiency and lowest toxicity of different nonviral transfection reagents. Lipid-mediated gene transfer is a promising approach to target corneal endothelial cells. Careful examination should be performed for optimal results with nonviral transfection reagents to use all their advantages.

Keywords: cornea: endothelium • gene transfer/gene therapy • flow cytometry 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.